Vividion Therapeutics competitorsClear all

Vividion Therapeutics's top competitors include Pfenex, Immunic, Enanta Pharmaceuticals and U.S. Stem Cell.
Vividion Therapeutics
Vividion Therapeutics
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.
Pfenex
Pfenex
Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.
Immunic
Immunic
Immunic (previously known as Vital Therapies) is a biopharmaceutical company developing a pipeline of selective oral immunology therapies.
Enanta Pharmaceuticals
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
U.S. Stem Cell
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Founding Date
Founding Date
2013
Founding Date
2009
Founding Date
2003
Founding Date
1998
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
San Diego, US HQ
Locations
New York, US HQ
Planegg, DE
Locations
Watertown, US HQ
Watertown, US
Locations
Sunrise, US HQ
Sunrise, US
Employees
Employees
N/A
Employees
836% increase
Employees
26160% increase
Employees
13217% increase
Employees
10
Valuation ($)
Valuation ($)
N/A
Valuation ($)
439 m
Valuation ($)
340.2 m
Valuation ($)
886.2 m
Valuation ($)
1.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
4.2 k
Twitter followers
253
Twitter followers
N/A
Twitter followers
1.8 k
Alexa Website Rank
Alexa Website Rank
401483
Alexa Website Rank
428067
Alexa Website Rank
312508
Alexa Website Rank
341280
Alexa Website Rank
299731
Employee Rating
Employee Rating
5
Employee Rating
2.6
Employee Rating
3.8
Employee Rating
4.4
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$50.3m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$205.2m (FY, 2019)
Revenue (est.)
$6.7m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$4.9m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.1m (FY, 2018)
Gross profit
Gross profit
N/A
Gross profit
$45.4m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$4.6m (FY, 2018)
Net income
Net income
N/A
Net income
$1.1m (FY, 2019)
Net income
($34.9m) (FY, 2019)
Net income
$46.4m (FY, 2019)
Net income
($2.2m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 236.5m
Total funding raised
$ 24m
Total funding raised
$ 160.2m
Total funding raised
$ 9.2m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Pfenex
HQ
San Diego, US
Employees
83↑ 6% increase

Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.

View company
Immunic
HQ
New York, US
Employees
26

Immunic (previously known as Vital Therapies) is a biopharmaceutical company developing a pipeline of selective oral immunology therapies.

View company
Enanta Pharmaceuticals
HQ
Watertown, US
Employees
132↑ 17% increase

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.

View company
U.S. Stem Cell
HQ
Sunrise, US
Employees
10

U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

View company